Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Can J Clin. 2018;68:394–424.

Article  Google Scholar 

Sato J, Kitagawa Y, Watanabe S, Asaka T, Ohga N, Hirata K, et al. Hypoxic volume evaluated by 18F-fluoromisonidazole positron emission tomography (FMISO-PET) may be a prognostic factor in patients with oral squamous cell carcinoma: preliminary analyses. Int J Oral Maxillofac Surg. 2018;47:553–60.

Article  CAS  PubMed  Google Scholar 

Zhu A, Lee D, Shim H. Metabolic positron emission tomography imaging in cancer detection and therapy response. Semin Oncol. 2011;38:55–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yonezawa N, Minamikawa T, Kitajima K, Takahashi Y, Sasaki R, Nibu KI, et al. The maximum standardized uptake value increment calculated by dual-time-point (18) F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma. Nagoya J Med Sci. 2017;79:189–98.

CAS  PubMed  PubMed Central  Google Scholar 

Uchiyama Y, Hirata K, Watanabe S, Okamoto S, Shiga T, Okada K, et al. Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma. Ann Nucl Med. 2021;35:1223–31.

Article  CAS  PubMed  Google Scholar 

Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET. Ann Nucl Med. 2008;22:533–8.

Article  PubMed  Google Scholar 

Kawase Y, Yamamoto Y, Kameyama R, Kawai N, Kudomi N, Nishiyama Y. Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma. Mol Imag Biol. 2011;13:1284–9.

Article  Google Scholar 

Okochi Y, Nihashi T, Fujii M, Kato K, Okada Y, Ando Y, et al. Clinical use of (11) C-methionine and (18) F-FDG-PET for germinoma in central nervous system. Ann Nucl Med. 2014;28:94–102.

Article  CAS  PubMed  Google Scholar 

Maffione AM, Grassetto G, Rampin L, Chondrogiannis S, Marzola MC, Ambrosini V, et al. Molecular imaging of pulmonary nodules. AJR Am J Roentgenol. 2014;202:217–23.

Article  Google Scholar 

Nakajima R, Kimura K, Abe K, Sakai S. 11C-methionine PET/CT findings in benign brain disease. Jpn J Radiol. 2017;35:279–88.

Article  CAS  PubMed  Google Scholar 

Lindholm P, Leskinen-Kallio S, Minn H, Bergman J, Haaparanta M, Lehikoinen P, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. J Nucl Med. 1993;34:1711–6.

CAS  PubMed  Google Scholar 

Lindholm P, Leskinen-Kallio S, Grénman R, Lehikoinen P, Någren K, Teräs M, et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and 11C-methionine. Int J Radiat Oncol Biol Phys. 1995;32:787–94.

Article  CAS  PubMed  Google Scholar 

Lindholm P, Leskinen S, Lapela M. Carbon-11-methionine uptake in squamous cell head and neck cancer. J Nucl Med. 1998;39:1393–7.

CAS  PubMed  Google Scholar 

Leskinen-Kallio S, Någren K, Lehikoinen P, Ruotsalainen U, Teräs M, Joensuu H. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med. 1992;33:691–5.

CAS  PubMed  Google Scholar 

Kobayashi K, Hirata K, Yamaguchi S, Manabe O, Terasaka S, Kobayashi H, et al. Prognostic value of volume-based measurements on (11) C-methionine PET in glioma patients. Eur J Nucl Med Mol Imag. 2015;42:1071–80.

Article  CAS  Google Scholar 

Yamaguchi S, Hirata K, Okamoto M, Shimosegawa E, Hatazawa J, Hirayama R, et al. Determination of brain tumor recurrence using 11 C-methionine positron emission tomography after radiotherapy. Can Sci. 2021;112:4246–56.

Article  CAS  Google Scholar 

Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. J Nucl Med. 1993;34:1886–91.

CAS  PubMed  Google Scholar 

Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med. 1993;34:1936–43.

CAS  PubMed  Google Scholar 

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AA, editors. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009.

Google Scholar 

Ramos CD, Erdi YE, Gonen M, Riedel E, Yeung HW, Macapinlac HA, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med. 2001;28:155–64.

Article  CAS  PubMed  Google Scholar 

Yamamoto F, Tsukamoto E, Nakada K, Takei T, Zhao S, Asaka M, et al. 18F-FDG PET is superior to 67Ga SPECT in the staging of non-hodgkin’s lymphoma. Ann Nucl Med. 2004;18:519–26.

Article  PubMed  Google Scholar 

Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Yamamoto N, et al. Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-d-glucose accumulations in the oral cavity of patients with oral cancers. Dentomaxillofac Radiol. 2013;42:20130014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med. 1994;35:104–12.

CAS  PubMed  Google Scholar 

Chan SC, Hsu CL, Yen TC, Ng SH, Liao CT, Wang HM. The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma. Oral Oncol. 2013;49:71–8.

Article  PubMed  Google Scholar 

Ryu IS, Kim JS, Roh JL, Cho KJ, Choi SH, Nam SY, et al. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18) F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Eur J Nucl Med Mol Imag. 2014;41:452–61.

Article  CAS  Google Scholar 

Isselbacher KJ. Increased uptake of amino acids and 2-deoxy-d-glucose by virus-transformed cells in culture. Proc Natl Acad Sci USA. 1972;69:585–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med. 1995;36:484–92.

CAS  PubMed  Google Scholar 

Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med. 2007;21:331–7.

Article  PubMed  Google Scholar 

Goksel S, Erdivanli OC, Bulbul O, Dursun E. The role of metabolic tumor parameters predicting cervical lymph node metastasis in patients with head and neck squamous cell carcinoma. J Can Res Ther. 2022;18:1045–51.

Article  CAS  Google Scholar 

Yamada T, Uchida M, Kwang-Lee K, et al. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:464–71.

Article  PubMed  Google Scholar